Beranda524804 • BOM
add
Aurobindo Pharma Ltd
Tutup sebelumnya
₹1.176,65
Rentang hari
₹1.157,05 - ₹1.178,35
Rentang tahun
₹994,35 - ₹1.364,95
Kapitalisasi pasar
674,02 M INR
Volume Rata-Rata
42,41 rb
Rasio P/E
19,96
Hasil dividen
0,34%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (INR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 82,86 M | 6,28% |
Biaya operasional | 36,98 M | 8,70% |
Penghasilan bersih | 8,48 M | 3,80% |
Margin laba bersih | 10,24 | -2,29% |
Penghasilan per saham | 14,61 | 4,36% |
EBITDA | 16,66 M | 5,66% |
Tarif pajak efektif | 33,53% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 88,92 M | 29,47% |
Total aset | 525,46 M | 9,26% |
Total liabilitas | 175,12 M | 1,76% |
Total ekuitas | 350,34 M | — |
Saham yang beredar | 580,73 jt | — |
Harga terhadap nilai buku | 1,95 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 7,46% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 8,48 M | 3,80% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
Didirikan
1986
Kantor pusat
Situs
Karyawan
27.707
